Precision Medicine Market Size, Demand, Competitive Analysis, Growth and Forecast 2022-2027 

The IMARC Group provides extensive analysis of the precision medicine industry covering the market trends, investment opportunities, growth trends, statistics, and industry prospects. The report offers a comprehensive analysis of the industry, which comprises insights on precision medicine market size, share, trends, analysis, growth, demand, statistics, and overview. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. The market is segmented by size and region. The report provides an analysis of the key trends in each sub-segment of the market, along with forecasts at the global and regional level from 2022-2027. The report also includes competitive landscape of major key players in the industry along with emerging trends in the market.

Informed covered in the report:

• Historical market data from 2016-2021
• CAGR of the market during the forecast period 2022-2027
• Detailed information on factors that will drive market growth during the next five years
• Precise estimation of the Keyword market size and its contribution to the parent market
• Upcoming market trends and changes in consumer behavior
• A thorough analysis of the market’s competitive landscape and detailed information on key players
• Comprehensive details of factors that will challenge the growth of smart meters market key players

Request for a PDF sample of this report: https://www.imarcgroup.com/precision-medicine-market/requestsample

The global precision medicine market reached a value of US$ 61.0 Billion in 2021. Precision medicine represents a medical approach to prevent and diagnose diseases by depending on an individual variability of genes, environment, lifestyle, etc. It aids in predicting the susceptibility to an illness, improving disease detection and progression, customizing strategies, prescribing effective drugs, etc. Precision medicine also helps make associated healthcare decisions, enhance care quality, eliminate trial-and-error inefficiencies, etc. Furthermore, as it reduces the time, cost, and failure rate of pharmaceutical clinical trials, precision medicine is extensively utilized in guiding therapy for chronic diseases, diagnosing cancer and chromosomal abnormalities of the fetus, predicting the risk of passing on genetic disorders to offspring, etc.

Precision Medicine Market Trends:

The sudden outbreak of the COVID-19 pandemic is leading to the rising requirement to study the coronavirus and its susceptibility, impact, potential therapies, etc. This is among the primary factors driving the precision medicine market. Moreover, the escalating prevalence of cancer and the growing number of drug candidates under clinical trials are further catalyzing the market growth. Besides this, the introduction of numerous cutting-edge and cost-effective techniques, such as whole-genome sequencing and targeted sequencing, for studying genomes and creating personalized therapies, is acting as another significant growth-inducing factor. Additionally, the elevating adoption of Big Data to analyze electronic health records is expected to stimulate the precision medicine market in the coming years. Looking forward, IMARC Group expects the precision medicine market to reach US$ 112.8 Billion by 2027, exhibiting at a CAGR of 10.1% during 2022-2027.

Checkout Now: https://www.imarcgroup.com/checkout?id=4567&method=1

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Competitive Landscape with Key Players:

• AstraZeneca plc
• Bayer AG
• BioMérieux SA
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• Hoffmann-La Roche AG
• Illumina Inc.
• Laboratory Corporation of America Holdings
• Merck KGaA, Novartis AG
• Pfizer Inc.
• Qiagen N.V.
• Quest Diagnostics Incorporated
• Thermo Fisher Scientific Inc.

Market Segmentation:

Product:

• Consumables
• Instruments
• Services

Technology:

• Big Data Analytics
• Bioinformatics
• Gene Sequencing
• Drug Discovery
• Companion Diagnostics
• Others

Application:

• Oncology
• Central Nervous System (CNS)
• Immunology
• Respiratory Medicine
• Infections
• Others

End User:

• Hospitals and Clinics
• Diagnostic Centers
• Pharma and Biotech Companies
• Healthcare IT Firms
• Others

Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/precision-medicine-market

Key highlights of the report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Also Read: Plastic Pallets Market Growth, Upcoming Trends, Companies Share, Structure and Analysis 2022-2027